Caballero, Miguel
Overview
| Works: | 13 works in 13 publications in 2 languages and 16 library holdings |
|---|---|
| Genres: | Independent films Drama Romance films Short films |
| Roles: | Author, Contributor, Actor |
| Classifications: | PN1993.43.D4, 617.5 |
Publication Timeline
.
Most widely held works by
Miguel Caballero
Neck mass and tracheostomy in a young lady depicted by Piero di Cosimo by
Juan J Grau(
)
1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide
p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related
carcinomas by
Llucia Alos(
)
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
Influence of allelic variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer
treated with radiotherapy plus cetuximab by Carmen Muñoz(
)
1 edition published in 2015 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2015 in English and held by 2 WorldCat member libraries worldwide
La investigaci n y el desarrollo tecnol gico forestal en m xico by
Miguel Caballero(
Book
)
1 edition published in 2012 in English and held by 1 WorldCat member library worldwide
1 edition published in 2012 in English and held by 1 WorldCat member library worldwide
Nuevos conceptos en muerte subita by Martin C Moyano(
)
1 edition published in 1997 in Spanish and held by 1 WorldCat member library worldwide
1 edition published in 1997 in Spanish and held by 1 WorldCat member library worldwide
[Carta], 1938 nov. 18, Santa Fé [Argentina], a Agustín Arce by
Miguel Caballero(
)
1 edition published in 1938 in Spanish and held by 1 WorldCat member library worldwide
Le envía varias revistas con fotografías de su comunidad y algunos artículos, le preocupa la situación en Palestina y trata otros asuntos de la orden
1 edition published in 1938 in Spanish and held by 1 WorldCat member library worldwide
Le envía varias revistas con fotografías de su comunidad y algunos artículos, le preocupa la situación en Palestina y trata otros asuntos de la orden
El ADN de Power Pivot by
Miguel Caballero(
Book
)
1 edition published in 2016 in Spanish and held by 1 WorldCat member library worldwide
Power Pivot, antes escrito como PowerPivot sin espacios, junto con el Lenguaje DAX: ¡Componen una excelsa sinfonía de una revolución mágica y sin precedentes para Business Intelligence -BI-! es como si nos hubieran traído una tecnología de veinte años en el futuro para utilizarlos hoy en día. La capacidad de resumir cantidades masivas de datos, crear expresiones de todo tipo para extraer gemas de información, acompañado de la posibilidad de crear reportes de tablas dinámicas como nunca antes se había soñado, la convierten el arma letal para inteligencia de negocios (Business Intelligence -BI-) al alcance de todos.El ADN DE POWER PIVOT, es una guía paso a paso a sobre Power Pivot, Construcción de Modelos de Datos y el Lenguaje DAX, desde sus fundamentos esenciales hasta sus aspectos más avanzados y complejos, lleno de ejemplos, ilustraciones, ayudas visuales para dominar el arte de transformar datos en información útil para la toma de decisiones.Realiza análisis y reportes increíbles de la mano de Power Pivot para Excel y el Lenguaje DAX
1 edition published in 2016 in Spanish and held by 1 WorldCat member library worldwide
Power Pivot, antes escrito como PowerPivot sin espacios, junto con el Lenguaje DAX: ¡Componen una excelsa sinfonía de una revolución mágica y sin precedentes para Business Intelligence -BI-! es como si nos hubieran traído una tecnología de veinte años en el futuro para utilizarlos hoy en día. La capacidad de resumir cantidades masivas de datos, crear expresiones de todo tipo para extraer gemas de información, acompañado de la posibilidad de crear reportes de tablas dinámicas como nunca antes se había soñado, la convierten el arma letal para inteligencia de negocios (Business Intelligence -BI-) al alcance de todos.El ADN DE POWER PIVOT, es una guía paso a paso a sobre Power Pivot, Construcción de Modelos de Datos y el Lenguaje DAX, desde sus fundamentos esenciales hasta sus aspectos más avanzados y complejos, lleno de ejemplos, ilustraciones, ayudas visuales para dominar el arte de transformar datos en información útil para la toma de decisiones.Realiza análisis y reportes increíbles de la mano de Power Pivot para Excel y el Lenguaje DAX
Otorrinolaringología y neumología(
Book
)
1 edition published in 2008 in Spanish and held by 1 WorldCat member library worldwide
1 edition published in 2008 in Spanish and held by 1 WorldCat member library worldwide
Contestaciones completas al Programa para ingreso en el Cuerpo de Carteros Urbanos by
Miguel Caballero(
Book
)
1 edition published in 1931 in Spanish and held by 1 WorldCat member library worldwide
1 edition published in 1931 in Spanish and held by 1 WorldCat member library worldwide
Mandato civil; explicación y comentario by
Miguel Caballero(
Book
)
1 edition published in 1916 in Spanish and held by 1 WorldCat member library worldwide
1 edition published in 1916 in Spanish and held by 1 WorldCat member library worldwide
Estudio anatomopatológico de la utilización de silicona, cartílago autólogo y teflón para el tratamiento de la parálisis
unilateral de la cuerda vocal by
Miguel Caballero Borrego(
)
1 edition published in 2000 in Spanish and held by 1 WorldCat member library worldwide
1 edition published in 2000 in Spanish and held by 1 WorldCat member library worldwide
La primavera(
Visual
)
1 edition published in 2006 in English and held by 1 WorldCat member library worldwide
"A lyrical telling of an intimate encounter between a U.S Navy Sailor and a local Chilean woman, La Primavera delves into the fleeting moments of uncertainty and flux that test the bounds of emotional connection. The parting of this couple, though it is never quite seen, and barely spoken of, is what keeps the silent time ticking, the dirge-like Fado droning, and the worlds outside just audible enough to be bittersweet"--Http://www.imdb.com/title/tt0844478/plotsummary (as viewed on5/04/09)
1 edition published in 2006 in English and held by 1 WorldCat member library worldwide
"A lyrical telling of an intimate encounter between a U.S Navy Sailor and a local Chilean woman, La Primavera delves into the fleeting moments of uncertainty and flux that test the bounds of emotional connection. The parting of this couple, though it is never quite seen, and barely spoken of, is what keeps the silent time ticking, the dirge-like Fado droning, and the worlds outside just audible enough to be bittersweet"--Http://www.imdb.com/title/tt0844478/plotsummary (as viewed on5/04/09)
Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study(
)
in English and held by 1 WorldCat member library worldwide
Objectives: In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin plus 5-FU for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). With the aim of improving fluoropyrimidine-related tolerance without decreasing its efficacy, the safety and efficacy of carboplatin plus the oral fluoropyrimidine tegafur and cetuximab were investigated. Methods: A retrospective analysis of 104 patients with recurrent or metastatic HNSCC was conducted. Patients were treated with carboplatin (area under the curve: 5 mg/mL/min) on day 1, oral tegafur (250 mg/m twice daily) for 21 consecutive days, and cetuximab (400 mg/m as an initial 2-hour intravenous infusion, then 250 mg/m as a 1-hour weekly infusion for 3 weeks) for ≤6 cycles. Patients who responded to the therapy then received weekly cetuximab maintenance therapy. Results: Treatment was well tolerated with a high level of compliance (relative dose intensity: 96%, 88%, and 81% for carboplatin, tegafur, and cetuximab, respectively). Grade 3-4 adverse events (AEs) were observed in 38% of patients (skin reactions in 17% of patients, anemia 4%, and neutropenia 3%). Grade 1-2 AEs included skin reactions (52% of patients), hypomagnesemia (20%), asthenia (19%), and anemia (13%). No venous thrombosis related to chemotherapy perfusion was observed. Over a median follow-up of 21 months, the median overall and progression-free survival were 11 and 6 months, respectively, and the overall response rate was 35%. Conclusions: Carboplatin plus oral tegafur and cetuximab is a safe, well-tolerated first-line therapy for recurrent or metastatic HNSCC
in English and held by 1 WorldCat member library worldwide
Objectives: In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin plus 5-FU for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). With the aim of improving fluoropyrimidine-related tolerance without decreasing its efficacy, the safety and efficacy of carboplatin plus the oral fluoropyrimidine tegafur and cetuximab were investigated. Methods: A retrospective analysis of 104 patients with recurrent or metastatic HNSCC was conducted. Patients were treated with carboplatin (area under the curve: 5 mg/mL/min) on day 1, oral tegafur (250 mg/m twice daily) for 21 consecutive days, and cetuximab (400 mg/m as an initial 2-hour intravenous infusion, then 250 mg/m as a 1-hour weekly infusion for 3 weeks) for ≤6 cycles. Patients who responded to the therapy then received weekly cetuximab maintenance therapy. Results: Treatment was well tolerated with a high level of compliance (relative dose intensity: 96%, 88%, and 81% for carboplatin, tegafur, and cetuximab, respectively). Grade 3-4 adverse events (AEs) were observed in 38% of patients (skin reactions in 17% of patients, anemia 4%, and neutropenia 3%). Grade 1-2 AEs included skin reactions (52% of patients), hypomagnesemia (20%), asthenia (19%), and anemia (13%). No venous thrombosis related to chemotherapy perfusion was observed. Over a median follow-up of 21 months, the median overall and progression-free survival were 11 and 6 months, respectively, and the overall response rate was 35%. Conclusions: Carboplatin plus oral tegafur and cetuximab is a safe, well-tolerated first-line therapy for recurrent or metastatic HNSCC
more
fewer
Audience Level
| 0 |
 |
1 | ||
| Kids | General | Special | ||
Related Identities
- SpringerLink (Online service) Other
- Grau, Juan Jose Contributor
- Nadal, Alfons Contributor
- Ordi, Jaume Contributor
- Canalda, Sílvia
- Trilla, Antoni
- Guimera, Nuria Contributor
- Larque, Ana-Belen Contributor
- Grau, Juan J. Author
- Marti, Carles Contributor
Associated Subjects